findmyKOL
Clinical trialNCT01111058TerminatedPhase 2Interventional

Everolimus Versus Placebo in Head and Neck Cancer

SponsorUniversity of ChicagoEnrollment52Head and Neck Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Miami

    Miami, Florida, United States

  • Northwestern University

    Chicago, Illinois, United States

  • the University of Chicago Medical Center

    Chicago, Illinois, United States

  • University of Illinois-Chicago

    Chicago, Illinois, United States

  • Ingalls Cancer Research Center

    Harvey, Illinois, United States

  • University of Kansas

    Kansas City, Kansas, United States

  • Louisianna State University

    Shreveport, Louisiana, United States

  • Tufts Medical Center

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • University of Mississippi

    Jackson, Mississippi, United States

  • Washington University

    St Louis, Missouri, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Medical University of South Carolina Hollings Cancer Center

    Charleston, South Carolina, United States

  • Vanderbilt University

    Nashville, Tennessee, United States

  • the University of Texas Medical Branch at Galveston

    Galveston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2010
Primary completion
30 Apr 2018
Completion
31 Oct 2018
Last update posted
7 Apr 2020
Registered enrollment
52
Registry id
NCT01111058

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.